FX Shoulder Solutions Retrospective / Prospective Clinical Study
- Conditions
- Rotator Cuff Syndrome of Shoulder and Allied DisordersOsteoarthritis ShoulderFracture, Shoulder
- Interventions
- Device: FX Artificial Shoulder Prosthesis
- Registration Number
- NCT06077942
- Lead Sponsor
- FX Shoulder Solutions
- Brief Summary
Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.
- Detailed Description
To evaluate patient outcomes following shoulder replacement with FX Shoulder Solutions medical devices To demonstrate effectiveness, safety and survivorship of FX Shoulder Solutions medical devices To provide data and analysis to FX Shoulder Solutions to meet regulatory requirements.
To provide data and analysis for presentations, abstracts, publications and other public release of results.
Clinical data in the Investigator's clinic notes and patient files regarding demographics, baseline medical and shoulder status, surgical procedure and implant components, and any completed postoperative clinical data will be collected retrospectively as data for the Study following signed patient consent and enrollment into the study.
Each patient will be evaluated prospectively, and clinical data collected at the first baseline clinical evaluation using the protocol specified evaluations following study enrollment with successive postoperative evaluations in accordance with the postoperative intervals.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 600
- Received an FX Shoulder Solutions replacement medical device in accordance with the Indications for Use based upon surgeons' determination and standard of care for the selected device system beginning January 1, 2018, through June 30, 2023.
- Patient who does not meet the inclusion criteria above
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Subjects FX Artificial Shoulder Prosthesis Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.
- Primary Outcome Measures
Name Time Method Number of participants who are at a minimum of 2 years postoperative follow-up based upon the following composite clinical success (CCS) of the Patient Reported Outcome Surveys and Investigator Range of Motion (ROM) assessments. 10 years * Adjusted Constant Score \> 70
* No continuous radiolucency or device migration/subsidence
* No revision surgery or removal
* No serious device related adverse event
The Study will continue to follow patients prospectively to 10 years postoperative to track survivorship.
- Secondary Outcome Measures
Name Time Method American Shoulder and Elbow Surgeon (ASES) 3, 6, 12, 24 months, 5 and 10 years. ASES is a validated patient-reported outcome which is composed of 10 functional questions and one pain VAS. The total score is of 100 maximum points and weighted evenly between pain and function
Range of Motion 3, 6, 12, 24 months, 5 and 10 years. ROM - The patient performs active movements in all functional planes for the shoulder.
Includes flexion, extension, abduction, adduction and internal and external rotation. Investigator estimates the range of movement and compares the affected with the unaffected shoulder and the normal expected range.Number of Participants with Radiographic Reviews and Assessments. 24 months, at 5 years and 10 years postoperative Monitor implant integrity and signs of implant loosening
Number of Participants Who Have a Secondary Surgical Intervention (SSI) 24 months and at 5 and 10 years SSI's are re-operations, revisions, and removals.
Serious Adverse Device Effects (SADE) 24 months and at 5 and 10 years postoperative. Adverse device effect that has resulted in any of the consequences characteristic of a serious adverse event.
Adjusted Constant Score 3, 6, 12, 24 months, 5 and 10 years. The Constant-Murley score (CMS) is a validated 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion (40 points) with the subject completing the assessment prior to the Investigator completing their part of the assessment. The higher the score, the higher the quality of the function.
An Adjusted Constant score will be calculated using normalized values to account for age and gender, as based upon anatomical gender at birth.QuickDASH 3, 6, 12, 24 months, 5 and 10 years. QuickDASH measures an individual's ability to complete tasks, absorb forces, and severity of symptoms. The QuickDASH tool uses a 5-point Likert scale from which the patient can select an appropriate number corresponding to his/her severity level/ function level. The higher the score, the higher the function and lower pain in the patient.
Visual Analog Scale (VAS). A validated measurement of pain in a patient where 0 indicates no pain and 100 indicates severe pain. The VAS is a straight horizontal line of fixed length. 3, 6, 12, 24 months, 5 and 10 years A validated measurement of pain in a patient where 0 indicates no pain and 100 indicates severe pain. The VAS is a straight horizontal line of fixed length.
Device Related Adverse Events. 24 months and at 5 and 10 years postoperative An adverse event that is related to the use of a device.
Serious Adverse Event 24 months and at 5 and 10 years postoperative 1. Led to a death,
2. Resulted in life threatening illness or injury\*
3. Resulted in patient hospitalization or prolongation of existing hospitalization,
4. Resulted in patient disability or permanent damage or required intervention to prevent permanent impairment/damage
5. Led to a congenital abnormality or birth defect
Trial Locations
- Locations (2)
OrthoArizona
🇺🇸Gilbert, Arizona, United States
Advanced Orthopedics Institute
🇺🇸The Villages, Florida, United States